Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Advanced Glioma von Mellinghoff, Ingo K., Ellingson, Benjamin M., Touat, Mehdi, Maher, Elizabeth, De La Fuente, Macarena I., Holdhoff, Matthias, Cote, Gregory M., Burris, Howard, Janku, Filip, Young, Robert J., Huang, Raymond, Jiang, Liewen, Choe, Sung, Fan, Bin, Yen, Katharine, Lu, Min, Bowden, Chris, Steelman, Lori, Pandya, Shuchi S., Cloughesy, Timothy F., Wen, Patrick Y.

Volltext

Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial von Mellinghoff, Ingo K., Penas-Prado, Marta, Peters, Katherine B., Burris, Howard A., Maher, Elizabeth A., Janku, Filip, Cote, Gregory M., de la Fuente, Macarena, Clarke, Jennifer L., Ellingson, Benjamin M., Chun, Saewon, Young, Robert J., Liu, Hua, Choe, Sung, Lu, Min, Le, Kha, Hassan, Islam, Steelman, Lori, Pandya, Shuchi S., Cloughesy, Timothy F., Wen, Patrick Y.

Volltext

Resection versus biopsy in the treatment of multifocal glioblastoma: a weighted survival analysis von Di, Long, Heath, Rainya N., Shah, Ashish H., Sanjurjo, Alexander D., Eichberg, Daniel G., Luther, Evan M., de la Fuente, Macarena I., Komotar, Ricardo J., Ivan, Michael E.

Volltext

Bilateral radiation therapy followed by methotrexate‐based chemotherapy for primary vitreoretinal lymphoma von Fuente, Macarena I., Alderuccio, Juan Pablo, Reis, Isildinha M., Omuro, Antonio, Markoe, Arnold, Echegaray, Jose J., Davis, Janet L., Harbour, J. William, Lossos, Izidore S.

Volltext

Short survival and frequent transformation in extranodal marginal zone lymphoma with multiple mucosal sites presentation von Alderuccio, Juan Pablo, Zhao, Wei, Desai, Amrita, Ramdial, Jeremy, Gallastegui, Nicolas, Kimble, Erik, Fuente, Macarena I., Husnain, Muhammad, Rosenblatt, Joseph D., Alencar, Alvaro J., Schatz, Jonathan H., Moskowitz, Craig H., Chapman, Jennifer R., Vega, Francisco, Reis, Isildinha M., Lossos, Izidore S.

Volltext

Delineation of recurrent glioblastoma by whole brain spectroscopic magnetic resonance imaging von Bell, Jonathan B, Jin, William, Goryawala, Mohammed Z, Azzam, Gregory A, Abramowitz, Matthew C, Diwanji, Tejan, Ivan, Michael E, Del Pilar Guillermo Prieto Eibl, Maria, de la Fuente, Macarena I, Mellon, Eric A

Volltext

Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial von de la Fuente, Macarena I, Colman, Howard, Rosenthal, Mark, Van Tine, Brian A, Levacic, Danijela, Walbert, Tobias, Gan, Hui K, Vieito, Maria, Milhem, Mohammed M, Lipford, Kathryn, Forsyth, Sanjeev, Guichard, Sylvie M, Mikhailov, Yelena, Sedkov, Alexander, Brevard, Julie, Kelly, Patrick F, Mohamed, Hesham, Monga, Varun

Volltext

The role of bevacizumab in the treatment of glioblastoma von Diaz, Roberto Jose, Ali, Sheikh, Qadir, Mehreen Gull, De La Fuente, Macarena I., Ivan, Michael E., Komotar, Ricardo J.

Volltext

BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas von Brastianos, Priscilla K., Twohy, Erin, Geyer, Susan, Gerstner, Elizabeth R., Kaufmann, Timothy J., Tabrizi, Shervin, Kabat, Brian, Thierauf, Julia, Ruff, Michael W., Bota, Daniela A., Reardon, David A., Cohen, Adam L., De La Fuente, Macarena I., Lesser, Glenn J., Campian, Jian, Agarwalla, Pankaj K., Kumthekar, Priya, Mann, Bhupinder, Vora, Shivangi, Knopp, Michael, Iafrate, A. John, Curry, William T., Cahill, Daniel P., Shih, Helen A., Brown, Paul D., Santagata, Sandro, Barker, Fred G., Galanis, Evanthia

Volltext

Central nervous system emergencies in haematological malignancies von Fuente, Macarena I., Alderuccio, Juan Pablo, Lossos, Izidore S.

Volltext

Survival benefit of lobectomy for glioblastoma: moving towards radical supramaximal resection von Shah, Ashish H., Mahavadi, Anil, Di, Long, Sanjurjo, Alexander, Eichberg, Daniel G., Borowy, Veronica, Figueroa, Javier, Luther, Evan, de la Fuente, Macarena Ines, Semonche, Alexa, Ivan, Michael E., Komotar, Ricardo J.

Volltext

SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology von Chukwueke, Ugonma N, Vera, Elizabeth, Acquaye, Alvina, Hervey-Jumper, Shawn L, Odia, Yazmin, Klesse, Laura J, Dunbar, Erin, Sharma, Akanksha, Fonkem, Ekokobe, Thomas, Alissa A, Werbowetski-Ogilvie, Tamra E, Camelo-Piragua, Sandra, Gatson, Na Tosha N, de la Fuente, Macarena I, Armstrong, Terri S, Porter, Alyx B, Jackson, Sadhana

Volltext

Simulated Adaptive Radiotherapy for Shrinking Glioblastoma Resection Cavities on a Hybrid MRI-Linear Accelerator von Guevara, Beatriz, Cullison, Kaylie, Maziero, Danilo, Azzam, Gregory A, De La Fuente, Macarena I, Brown, Karen, Valderrama, Alessandro, Meshman, Jessica, Breto, Adrian, Ford, John Chetley, Mellon, Eric A

Volltext

A Deep Learning Approach for Automatic Segmentation during Daily MRI-Linac Radiotherapy of Glioblastoma von Breto, Adrian L, Cullison, Kaylie, Zacharaki, Evangelia I, Wallaengen, Veronica, Maziero, Danilo, Jones, Kolton, Valderrama, Alessandro, de la Fuente, Macarena I, Meshman, Jessica, Azzam, Gregory A, Ford, John C, Stoyanova, Radka, Mellon, Eric A

Volltext

Ivosidenib, an IDH1 inhibitor, in a patient with recurrent, IDH1 -mutant glioblastoma: a case report from a Phase I study von Tejera, Dalissa, Kushnirsky, Marina, Gultekin, Sakir H, Lu, Min, Steelman, Lori, de la Fuente, Macarena I

Volltext

Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma von Mellinghoff, Ingo K., van den Bent, Martin J., Blumenthal, Deborah T., Touat, Mehdi, Peters, Katherine B., Clarke, Jennifer, Mendez, Joe, Yust-Katz, Shlomit, Welsh, Liam, Mason, Warren P., Ducray, François, Umemura, Yoshie, Nabors, Burt, Holdhoff, Matthias, Hottinger, Andreas F., Arakawa, Yoshiki, Sepulveda, Juan M., Wick, Wolfgang, Soffietti, Riccardo, Perry, James R., Giglio, Pierre, de la Fuente, Macarena, Maher, Elizabeth A., Schoenfeld, Steven, Zhao, Dan, Pandya, Shuchi S., Steelman, Lori, Hassan, Islam, Wen, Patrick Y., Cloughesy, Timothy F.

Volltext

Validation of daily 0.35 T diffusion‐weighted MRI for MRI‐guided glioblastoma radiotherapy von Lutsik, Natalia, Nejad‐Davarani, Siamak P., Valderrama, Alessandro, Herr, Janette, Maziero, Danilo, Cullison, Kaylie, Azzam, Gregory A., Kubicek, Gregory J, Meshman, Jessica, Fuente, Macarena I., Armstrong, Tess, Mellon, Eric A.

Volltext

Risk Factors for Transformation to Higher-Grade Lymphoma and Its Impact on Survival in a Large Cohort of Patients With Marginal Zone Lymphoma From a Single Institution von Alderuccio, Juan Pablo, Zhao, Wei, Desai, Amrita, Gallastegui, Nicolas, Ramdial, Jeremy, Kimble, Erik, de la Fuente, Macarena I, Rosenblatt, Joseph D, Chapman, Jennifer R, Vega, Francisco, Reis, Isildinha M, Lossos, Izidore S

Volltext

Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma von de la Fuente, Macarena I, Young, Robert J, Rubel, Jennifer, Rosenblum, Marc, Tisnado, Jamie, Briggs, Samuel, Arevalo-Perez, Julio, Cross, Justin R, Campos, Carl, Straley, Kimberly, Zhu, Dongwei, Dong, Chuanhui, Thomas, Alissa, Omuro, Antonio A, Nolan, Craig P, Pentsova, Elena, Kaley, Thomas J, Oh, Jung H, Noeske, Ralph, Maher, Elizabeth, Choi, Changho, Gutin, Philip H, Holodny, Andrei I, Yen, Katharine, DeAngelis, Lisa M, Mellinghoff, Ingo K, Thakur, Sunitha B

Volltext

Dynamics of Daily Glioblastoma Evolution During Chemoradiation Therapy on the 0.35T Magnetic Resonance Imaging-Linear Accelerator von Cullison, Kaylie, Samimi, Kayla, Bell, Jonathan B., Maziero, Danilo, Valderrama, Alessandro, Breto, Adrian L., Jones, Kolton, De La Fuente, Macarena I., Kubicek, Gregory, Meshman, Jessica, Azzam, Gregory A., Ford, John C., Stoyanova, Radka, Mellon, Eric A.

Volltext